NAYADAYA-INC
23.9.2020 14:02:20 CEST | Business Wire | Press release
Study on the presidential election, conducted by NayaDaya, YouGov, and Statista, shows that U.S. citizens will vote to prevent the undesirable from happening.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200923005036/en/
The study reveals emotions and behavior of U.S. citizens, evoked by the election of Trump and Pence or Biden and Harris . The most chosen emotions are relief , disgust , fear , and disappointment – distribution varies between candidates.
“For U.S. voters the election is mostly about avoiding an undesirable result, not about being emotionally uplifted by the candidates,” says Marcello Mortillaro , Ph.D and Senior Scientist, Partner of NayaDaya Inc.
The most chosen emotion for Trump’s re-election is disengaging disgust that indicates violating voters’ moral standards. Pence is Trump’s reflection: His re-election evokes even more disgust but overall less emotions. In Biden’s case, the most common emotion is relief , implying avoidance of a threat.
Mortillaro explains: “As for Biden, almost half of Democrats feel relief , a positive emotion with a low engaging impact. Harris is unlike Biden. She arouses positive, engaging emotions of pride , admiration and joy.” Among Republicans, disgust and fear are the strongest emotions toward both Harris’ and Biden’s elections.
The NayaDaya® Emotional and Behavioral Intelligence, which is based on scientific research independently conducted by the University of Geneva, Switzerland, was used to analyze the U.S. voter emotions.
Voter emotions predict voter behavior and engagement – percentages for loyals:
- Trump 32%
- Pence 27%
- Biden 45%
- Harris 42%
Among the young (18-34), 47% are loyal to Biden, 27% to Trump. Among the African-Americans, 58% are loyal to Biden, only 13% to Trump. More than a quarter of respondents are not in favor of Democrats or Republicans; 31% of them are positively engaged in Trump, 37% in Biden.
“In the context of significant phenomena like presidential elections, emotions are our key to understanding different perspectives and their behavioral consequences. Through data, insight, empathy, and impact we empower responsible leaders, media, brands, and organizations to thrive and shape the world,” says NayaDaya’s CEO Timo Järvinen .
Study facts:
- YouGov online panel Sept 2-4, 2020
- Sample represents U.S. adult population
- N=1265, margin of error ±2.5 percentage points
Annex: Key findings
Full report and data: www.nayadaya.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005036/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences12.3.2026 14:00:00 CET | Press release
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Enodia has acquired Kezar’s assets from its Sec61-based discovery and development program. The acquisition enables Enodia to advance its understanding of Sec61 selectivity mechanisms, expanding biological and translational insights for faster progression toward key clinical milestones. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312627573/en/ Under the terms of the purchase agreement between Enodia and Kezar, Kezar w
Adtran to showcase industry-leading open optical networking for the AI era at OFC 202612.3.2026 14:00:00 CET | Press release
News summary: Adtran will show how intelligent optical networks can scale infrastructure while controlling power, complexity and security risks Highlights include LiteWave800™, an ultra‑low‑power 800G pluggable transceiver, which sets a new 1pJ/bit benchmark for intra‑data center connectivity Adtran will participate in OIF multi‑vendor interoperability demos and present European‑led innovation through advanced research projects Adtran today announced that it will showcase its latest optical innovations at OFC 2026, taking place from March 15 to 19 in Los Angeles. The company will outline how intelligent, secure and power‑efficient optical networks are shaping the next phase of AI infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311958018/en/ Adtran’s optical networking technology is helping build the foundation for the AI era. At Adtran’s booth (1001), visitors can explore solutions spanning ultra‑low‑power
Wellesley Hills Financial Goes Global: New London and New York Hubs Signal Aggressive Expansion into Transatlantic Fintech M&A12.3.2026 13:00:00 CET | Press release
With the addition of industry veterans Barry Davis and Bill Shraga, WHF strengthens its cross-border capabilities and scales its specialized Merchant Portfolios platform to a national level. Wellesley Hills Financial (“WHF”), a premier fintech and payments-focused investment bank spanning the lower to upper middle market, today announced a series of senior appointments and geographic expansions that further scale its global advisory platform and deepens its capabilities across the payments and fintech ecosystems. The firm has appointed Barry Davis as Executive Advisor, based in London, added Managing Director Bill Shraga in New York, and expanded its payments consulting subsidiary, Merchant Portfolios (“MP”), with the addition of EVPs Lance McCord in North Carolina and Nolan Pittman in Arizona. Strengthening Transatlantic Connectivity Barry Davis joins WHF as the firm’s first London-based Executive Advisor, marking a significant milestone in WHF’s international expansion. His appointme
Prodalim Strengthens its Functional Platform to Enter the Fast-Growing Nutraceutical Market with the Acquisition of Sylvestre, a Market Leader in Botanical Extracts Based in Brazil12.3.2026 11:45:00 CET | Press release
The acquisition positions Prodalim to deepen its fast-growing functional beverage solutions offering, accelerate its expansion into the US functional ingredients market, and broaden its presence across emerging markets Prodalim, a global leader in juice and specialty ingredients solutions, announced today the acquisition of Sylvestre, a leading Brazilian producer of botanicals and functional extracts addressing the nutraceutical market. Sylvestre’s existing owners and management team will remain with the company and support its integration into Prodalim’s platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312584318/en/ Founded in 1992 in Brazil, Sylvestre is a trusted supplier of high-quality natural ingredients, specializing in botanical extracts, fruit powders, superfruits, teas, and unique functional plant-based solutions sourced from the rich and diverse Brazilian flora. With a portfolio of more than 200 natural
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 202612.3.2026 11:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Stifel 2026 Virtual CNS Forum, from March 17-18, 2026, and will participate in a fireside chat on March 18, 2026, at 10:30am ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom